All Posts By

Smartkarma Daily Briefs

Daily Brief ESG: There Is Also a Difference in Perspective Between Investors and Companies on the Remuneration System and more

By | Daily Briefs, ESG

In today’s briefing:

  • There Is Also a Difference in Perspective Between Investors and Companies on the Remuneration System


There Is Also a Difference in Perspective Between Investors and Companies on the Remuneration System

By Aki Matsumoto

  • From the perspective of securing human resources, global companies have increased % of performance-based compensation and stock-based compensation, but there is still large gap between them and many other companies.
  • Most Prime Market-listed companies have established remuneration committees, but do not disclose individual executive compensation, raising doubts about the transparency of the remuneration decision-making process.
  • As an element of performance-based compensation, many companies still place far greater emphasis on profits than on capital profitability, which leads to a difference in perspective with investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Crypto Week and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Crypto Week
  • Japan Morning Connection: Oil Down and Defense up as Trump Rails at Putin and Sends More Patriots
  • Jewellery Q1FY26 Report: Winners and Themes Amidst ₹1 Lakh Gold
  • Monday Delight: 14/07/25
  • The Sugar Sector Reversal: How Sugar Companies Are Finally Tasting Profits?
  • US Banks – New Loans Up USD119bn in past 3 Weeks. There Is No Recent Comparative This High.


Ohayo Japan | Crypto Week

By Mark Chadwick

  • Nasdaq closed at a record high, rising 0.3%; S&P 500 and Dow edged up 0.1% and 0.2%.
  • Trump threatened 100% secondary tariffs on Russia and announced new U.S. weapons for Ukraine via NATO
  • Sansan’s FY2025 results show net sales up 28% to ¥43.2 billion, driven by a 59% increase in Bill One sales

Japan Morning Connection: Oil Down and Defense up as Trump Rails at Putin and Sends More Patriots

By Andrew Jackson

  • AI and tech took a backseat, although momentum significantly outperformed value which is likely to be reflected in JP.
  • Trend Micro may be in focus after analyst pushes cyber security as biggest tech trade this year.
  • KHI looking to release its own humanoid, but Harmonic joints are out of favor and worth another look after steep decline.

Jewellery Q1FY26 Report: Winners and Themes Amidst ₹1 Lakh Gold

By Nimish Maheshwari

  • Organised jewellery players delivered strong revenue growth despite a 30% YoY gold price spike, driven by festive demand, ticket-size expansion, and formalisation.
  • Q1 trends highlight a shift toward lightweight, low-carat designs reiterated by Titan Co Ltd (TTAN IN) , with digital channels and franchising gaining momentum across the board.
  • With retail expansion and working capital discipline in focus, the players like Sky Gold appears poised for multi-format growth, aided by regulatory tailwinds and rising consumer trust.

Monday Delight: 14/07/25

By Contrarian Cashflows

  • Each week, I’ll share five intriguing investment ideas that recently caught my attention. These ideas are meant to spark your research and help you kickstart the week ahead with fresh insights.
  • Because these ideas are the result of my first-level idea generation process, they require more in depth research. Therefore, the ideas will often be concise, with occasional references to valuable work from other practitioners that I encourage you to explore.
  • If you have something fascinating to share that could benefit me and the wider community, don’t hesitate to send it my way—I’d love to hear from you!

The Sugar Sector Reversal: How Sugar Companies Are Finally Tasting Profits?

By Nimish Maheshwari

  • India’s sugar industry is experiencing an unexpected rally driven by pricing power due to an 18% production drop, leading to rising sugar prices.
  • This shift is boosting sugar mills’ profitability, as evidenced by improved quarterly results, despite unchanged ethanol margins and rising cane costs.
  • The sector is now a compelling “margin-driven” recovery story, moving beyond its traditionally dull, regulation-heavy image.

US Banks – New Loans Up USD119bn in past 3 Weeks. There Is No Recent Comparative This High.

By Daniel Tabbush

  • Weekly loan data is up a lot in week ending 2 July suggesting the geopolitical events are not negating credit demand in the US – demand is accelerating.
  • Over the past three weeks loans are up USD119bn and there is no other 3 week period that compares in recent months. 
  • Total loan growth is now 4.2% YoY where C&I loan growth accelerated from 2.3% YoY to 3.2% YoY, in the most recent week.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Ascentage Pharma Top-Up Placement – Past Deals Didn’t Done Well and more

By | Daily Briefs, ECM

In today’s briefing:

  • Ascentage Pharma Top-Up Placement – Past Deals Didn’t Done Well, Stock up a Lot but Sector Is Strong
  • Travel Food Services IPO Trading – Decent Anchor; Subdued Overall Demand
  • Anthem Biosciences IPO – Thoughts on Peer Comp and Valuation
  • Pre-IPO Busy Ming Group – Concerns Behind the High Growth
  • MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation
  • McGraw Hill, Inc. (MH): Legacy Education Company Sets Terms, Down-Round from 2021 Purchase
  • NIQ Global Intelligence Plc (NIQ): Advent-Backed, Consumer Intelligence Company Sets Terms for IPO
  • Kasumigaseki Hotel REIT Pre-IPO: Young Hotel Assets and Improving Economics


Ascentage Pharma Top-Up Placement – Past Deals Didn’t Done Well, Stock up a Lot but Sector Is Strong

By Sumeet Singh

  • Ascentage Pharma Group Corp (6855 HK) (AP) aims to raise around US$196m via  top-up placement.
  • The company has undertaken a number of deals in the past, with none of the deals having done well. Although stock momentum has been strong this year.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Travel Food Services IPO Trading – Decent Anchor; Subdued Overall Demand

By Akshat Shah

  • Travel Food Services Ltd (1450229D IN) raised about US$233m in its India IPO.
  • Travel Food Services Limited (TFS) operates a network of travel quick service restaurants (Travel QSRs) and private lounges in airports.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

Anthem Biosciences IPO – Thoughts on Peer Comp and Valuation

By Akshat Shah

  • Anthem Biosciences (1234D IN) is looking to raise about US$397m in its India IPO.
  • Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
  • We have looked at the company’s past performance in our previous notes. In this note, we will talk about the peer comp and IPO valuations.

Pre-IPO Busy Ming Group – Concerns Behind the High Growth

By Xinyao (Criss) Wang

  • BUSY MING operates under the franchise model, under which franchisees and BUSY MING form collaboration and a virtuous cycle, benefiting from the ecological logic of high turnover.
  • However, the potential risk is increasing homogeneous competition. Price wars and competitors’ rapid expansion would further squeeze the profit margin of BUSY MING and lead to market oversaturation.
  • The current high growth may not sustain.BUSY MING clearly hopes to successfully IPO during the current peak period of performance, but investors may face a decline in performance after IPO.

MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation

By Andrei Zakharov

  • MegaRobo Technologies, AI & robotics unicorn with focus on lab automation in life sciences and intelligent manufacturing, files to list IPO on Hong Kong Stock Exchange.
  • Founder led, AI native company was backed by Sinovation Ventures, Goldman Sachs, Asia Investment Capital, Robert Bosch Venture Capital, GGV Capital, and Joy Capital, among others.
  • The business is growing fast and increases the number of use cases across new verticals. However, negative free cash flows and operating losses are a headwind.

McGraw Hill, Inc. (MH): Legacy Education Company Sets Terms, Down-Round from 2021 Purchase

By IPO Boutique

  • McGraw Hill is offering 24.39mm shares at $19.00-$22.00 equating to a market cap of $3.6b-$4.2b and is scheduled to debut on July 24th.
  • The company is backed by Platinum Equity, a private equity firm that acquired the company from Apollo Global Management for approximately $4.5 billion in August 2021. 
  • Private Equity IPOs are to be a theme in the 2H of 2025 and McGraw Hill will be a test for the market based on the financial profile.

NIQ Global Intelligence Plc (NIQ): Advent-Backed, Consumer Intelligence Company Sets Terms for IPO

By IPO Boutique

  • NIQ Global Intelligence plc is offering 50.0mm shares at $20.00-$24.00 equating to a market cap of $5.9b-$7.1b and is scheduled to debut on July 23rd.
  • If successful, this will be the third IPO to raise $1 billion in 2025. 
  • NIQ Global Intelligence has a boat-load of debt, is private-equity backed but has a growth profile that is promising. We believe price sensitivity may play a role.

Kasumigaseki Hotel REIT Pre-IPO: Young Hotel Assets and Improving Economics

By Nicholas Tan


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group
  • Long-end treasury yields rose on Friday, amid US President Donald Trump’s threats of a 35% tariff on Canadian goods and a 15-20% baseline tariff on other countries without deals. The UST curve bear steepened, with the yield on the 2Y UST rising 1 bp to 3.88%, while that on the 10Y UST was up 6 bps at 4.41%. Equities retreated from all-time highs, with the S&P 500 and Nasdaq down 0.3% and 0.2%, at 6,260 and 20,586, respectively.
  • Mr Trump has shared tariff-letter screenshots on Truth Social to announce a 30% tariff on goods from the EU and Mexico, which are separate from all sectoral tariffs. The letters warn that “goods transhipped to evade a higher tariff will be subject to that higher tariff”, and “if for any reason you decide to raise your tariffs and retaliate, then, whatever the number you choose to raise them by, will be added onto the 30% that we charge”.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: GMO Internet (4784) – Shares Appear Manipulated/Squeezed (Again) and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • GMO Internet (4784) – Shares Appear Manipulated/Squeezed (Again), but ParentCo MUST SELL
  • [Japan M&A] Polaris MBO for DD Group (3073) – Too Light But Probably a Done Deal
  • Samsung Daily Buyback Flow Compiled (Excel): Notable Flow/Price Sync Pattern Identified
  • Guangdong-Hong Kong Greater Bay Area (1396 HK): This Doesn’t Add Up
  • DD Group (3073 JP): Polaris Capital-Sponsored MBO Is Light
  • Abacus Storage King (ASK AU): Ki Corp/Public Storage’s Revised NBIO Faces a Daunting Challenge
  • Merger and Acquisition Updates: GLXZ, OCFT, ASLI:L, and CPPTL’s Strategic Developments
  • BPER–Sondrio: 3.9% Spread with Optionality on Reopening


GMO Internet (4784) – Shares Appear Manipulated/Squeezed (Again), but ParentCo MUST SELL

By Travis Lundy

  • GMO Internet (4784 JP) was squeezed after a merger which was a Reverse Takeover followed by a ridiculous TOPIX inclusion. Then the parent tried an offering, which failed. 
  • The clearing price demanded was WAAAY lower so the offering was pulled. Shares fell 70%, then bounced 65%. Now 48x book and 66x EBITDA for an ISP. Super expensive. Manipulated.
  • ParentCo needs to sell 90mm shares ASAP. The only clean way is through a liquidation trust to get shares lower before a larger offering.

[Japan M&A] Polaris MBO for DD Group (3073) – Too Light But Probably a Done Deal

By Travis Lundy

  • Diamond Dining (3073 JP) (DD Group) head Matsumura-san appears to be getting out in this Polaris MBO for the dining group. 
  • The premium is low, and the the price is probably light, but there are a couple of small things which mean it isn’t quite as light as it might look. 
  • But the company prints cash, so yeah, it’s light. This should probably be a bit better, but F&B is a fickle business. 

Samsung Daily Buyback Flow Compiled (Excel): Notable Flow/Price Sync Pattern Identified

By Sanghyun Park

  • Daily buyback flow data for Samsung (ord + pref) since last Nov compiled — Excel file attached below.
  • Started with ~1M/day (for ord), ramped up at 20–30%, then tapered post-60% — same playbook in both legs, with the second showing even more methodical, steady pacing.
  • Price action tracked buyback flow closely — especially in leg 2, where the mid-heavy-light volume pattern showed strong consistency.

Guangdong-Hong Kong Greater Bay Area (1396 HK): This Doesn’t Add Up

By David Blennerhassett

  • Property developer Guangdong – Hong Kong Greater Bay Area Holdings (1396 HK) (GHKGBA) is currently suspended pursuant to the Takeovers Code.
  • GHKGBA, previously known as Hydoo, was subject to an unconditional MGO in 2019 after China Guangdong-Hong Kong Greater Bay Area (CGHKGBA) acquired a 51.56%.  CGHKGBA currently holds a 50.94% stake
  • At a guess, CGHKGBA will seek to take GHKGBA private by way of a Scheme. The rub/pushback? GHKGBA’s share price is up 2,383% YTD. And trailing P/B is ~7x. 

DD Group (3073 JP): Polaris Capital-Sponsored MBO Is Light

By Arun George

  • Diamond Dining (3073 JP) has recommended a Polaris Capital-sponsored MBO at JPY1,700, a 17.8% premium to the last close price.
  • The offer is light and is 16% below the midpoint of the IFA DCF valuation range. The process was lacking as there was no auction. 
  • DD has no recent history of activism. Therefore, the likelihood of a bump is low unless there is vocal opposition or an activist becomes a substantial shareholder. 

Abacus Storage King (ASK AU): Ki Corp/Public Storage’s Revised NBIO Faces a Daunting Challenge

By Arun George

  • Abacus Storage King (ASK AU) disclosed a non-binding proposal from Ki Corporation and Public Storage (PSA US) at A$1.65 per unit, a 14.7% premium to its previously rejected offer.
  • The Board will grant six weeks of due diligence. While below NTA (implies P/NTA of 0.95x), the offer is reasonable compared to peer multiples and historical trading ranges.   
  • The consortium will likely need to switch to a takeover offer as National Storage REIT (NSR AU), which holds effectively a blocking stake, is unlikely to vote in favour. 

Merger and Acquisition Updates: GLXZ, OCFT, ASLI:L, and CPPTL’s Strategic Developments

By Special Situation Investments

  • Galaxy Gaming (GLXZ) merger with Evolution AB is pending gaming regulatory review, with a 14% spread remaining.
  • OneConnect Financial Technology (OCFT) secured antitrust approval from SAMR for Ping An takeover, narrowing spread to 5%.
  • abrdn European Logistics Income (ASLI:L) sold two warehouses at a premium, with further asset sales in advanced discussions.

BPER–Sondrio: 3.9% Spread with Optionality on Reopening

By Jesus Rodriguez Aguilar

  • BPER acquired 58.35% of Sondrio with an enhanced bid, but low take-up signals shareholder dissatisfaction and opens room for further action.
  • Revised terms imply a 3.9% gross spread, offering a compelling short-term arbitrage play with estimated 12.4% annualized return.
  • A potential reopening or share accumulation remains likely, with Unipol’s dual role adding strategic weight and optionality to the situation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: BYD (1211 HK): Sales Volume Slowing Down in 2Q25 and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • BYD (1211 HK): Sales Volume Slowing Down in 2Q25, But Competitors Facing Cash Flow Stress
  • Supreme Court’s Final Ruling on Samsung’s Lee Jae-Yong on 17 July: Impact on Samsung Group Companies
  • Hikari Tsushin’s Portfolio
  • Anthem BioSciences IPO Analysis ~ The Fastest-Growing Indian CRDMO
  • Anthem Biosciences IPO: Despite 100% OFS, Worth Accumulating for Long-Term Compounding
  • UnitedHealth Group’s Bold Healthcare Transformation—Is This The Future of Affordable Medicine?
  • CICC (3908 HK): It Is the Best of the Time
  • Intel Layoffs Finally Kick Off With A Chaotic Start In Oregon
  • Treasure Chest: CSL Not A One-Trick Pony
  • Astellas Pharma (4503 JP): Izervay on Strong Footing, Strategic Brands Key for Future


BYD (1211 HK): Sales Volume Slowing Down in 2Q25, But Competitors Facing Cash Flow Stress

By Ming Lu

  • The sales volume growth rate slowed down month by month in 2Q25.
  • The domestic sales volume was stagnant in 2Q25 and decreased YoY from March to June.
  • However, competitors expanded aggressively; therefore, we believe small ones may go bankrupt.

Supreme Court’s Final Ruling on Samsung’s Lee Jae-Yong on 17 July: Impact on Samsung Group Companies

By Douglas Kim

  • The Supreme Court of Korea plans to make a final ruling on Samsung’s Lee Jae-Yong on 17 July.
  • If the Supreme Court confirms this appellate court’s ruling, then Lee Jae-Yong would finally be cleared of all charges related to the Samsung C&T and Cheil Industries merger. 
  • The market is mostly expecting the confirmation of “not guilty” on all 19 charges on Lee Jae-Yong.

Hikari Tsushin’s Portfolio

By Michael Fritzell

  • This write-up is about Hikari Tsushin — a Japanese sales organization run by a visionary founder called Yasumitsu Shigeta

  • It’s been much talked about on Twitter and Substack, but few of the write-ups discuss Hikari Tsushin’s portfolio of publicly listed equities

  • I am personally not particularly interested in Hikari Tsushin itself, as it is primarily a sales organization helping other businesses find customers


Anthem BioSciences IPO Analysis ~ The Fastest-Growing Indian CRDMO

By Sudarshan Bhandari

  • Anthem Biosciences (1234D IN) is launching a 3,395 crore IPO via a complete OFS, with a price band of INR 540–570 per share, open from July 14 to July 16.
  • Company is a fully integrated CRDMO with capabilities across drug discovery, development, and manufacturing for both small molecules and biologics, serving 550+ customers globally.
  • The company is undertaking a major capacity expansion, set to make its fermentation capacity over 6x larger than the second-largest Indian CRDMO player post-expansion.

Anthem Biosciences IPO: Despite 100% OFS, Worth Accumulating for Long-Term Compounding

By Sreemant Dudhoria,CFA

  • Strong Revenue Momentum and Profitability:Anthem Biosciences (1234D IN) achieved INR 18.4bn in revenue in FY25, growing 25% CAGR over FY20–FY25,with industry-leading EBITDA margins of 36.8% and PAT margin of 23.4%
  • Unique Dual Capability in Biologics and Small Molecules:Among the few Indian CRDMOs with end-to-end capabilities across both small and large molecules, and technology-driven portfolio including ADCs, RNAi, peptides, and oligonucleotides
  • Peer-Leading Returns and Robust Pipeline: Anthem boasts the highest ROCE (26.9%) among Indian peers, with significant IP-backed revenue streams and global molecule commercialization. It is a BUY for long term.

UnitedHealth Group’s Bold Healthcare Transformation—Is This The Future of Affordable Medicine?

By Baptista Research

  • UnitedHealth Group’s first quarter 2025 results reveal a number of positive developments alongside several challenges that have led to a downward revision of the company’s adjusted earnings per share outlook.
  • The company now expects an adjusted earnings per share range of $26 to $26.50, down from previous estimates, partly attributed to higher-than-expected care activity within its Medicare Advantage business and changes in member profiles impacting revenue at Optum Health.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

CICC (3908 HK): It Is the Best of the Time

By Osbert Tang, CFA

  • China International Capital Corporation (3908 HK)‘s 1H25 positive profit alert is encouraging, with 1H25 results growing by 55-78% YoY.  
  • YTD, CICC has a 59.5% share of the HK IPO market. The solid H-share IPO pipeline of A-share companies is beneficial, as this is its major area of strength.
  • Market consensus has underestimated its FY25 earnings, inflating its PER multiples. The current 51% discount of its H-share to A-share is just too steep (average 37.7%).

Intel Layoffs Finally Kick Off With A Chaotic Start In Oregon

By William Keating

  • Despite initially WARNing of 529 job cuts in Oregon, the actual number turned out to be 2,392
  • Only 9% of the Oregon cuts are in management positions
  • Huge cuts in technical employees across the board with a total of thirty Principal Engineers losing their jobs in Oregon alone.

Treasure Chest: CSL Not A One-Trick Pony

By FNArena

  • FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.
  • Today’s idea is on CSL

Astellas Pharma (4503 JP): Izervay on Strong Footing, Strategic Brands Key for Future

By Tina Banerjee

  • Astellas Pharma (4503 JP) announced that in Q1FY26 the sales of their drug Izervay (avacincaptad pegol intravitreal solution) in the U.S. market will be ¥15.9B (~$110M, up 25% YoY).
  • Strategic brands (Padcev, Izervay, Veozah, Vyloy, and Xospata) revenue expanded to ¥336B (+¥176B or +110% YoY) in FY25, representing 18% of the total revenue.
  • Astellas agreement with Evopoint Biosciences for a novel investigational clinical-stage antibody-drug conjugate (ADC) targeting CLDN18.2, will help expand its pipeline and augurs well given its expertise in similar therapies (Vyloy).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Asia Cross Asset: Liberation Day 2.0 and Asia and more

By | Daily Briefs, Macro

In today’s briefing:

  • Asia Cross Asset: Liberation Day 2.0 and Asia
  • Tuning Tariff Impact Estimates
  • European Tire Rubber Sector Faces Structural, Regulatory Headwinds
  • Korea: Short Selling Data Analysis: 3Q 2025
  • Asian Equities: Foreign Flows – Some Strength, Some Sustained Disappointments
  • Global FX: Keeping the bearish USD view
  • Global Commodities: 50% copper tariffs coming soon; now comes the copper hangover
  • Don’t Get Fooled by Commodity Social Media Craziness
  • Bank of Japan on Hold
  • Asia base oils demand outlook: Week of 14 July


Asia Cross Asset: Liberation Day 2.0 and Asia

By At Any Rate

  • Not surprised by recent events in the equity market, as it aligns with forecasted growth trends in Asia
  • Transitory factors such as front loading and transshipment contributing to expected decline in H2 growth
  • Expectation for central banks in the region to potentially ease rates in response to current economic conditions

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Tuning Tariff Impact Estimates

By Phil Rush

  • President Trump’s tariff policy seemingly follows a random walk with a drift towards deals. Path dependency raises risks and uncertainty around his volatile whims.
  • Corporate avoidance measures have spared their customers from most of the pain, but Vietnam’s deal as a template could belatedly bring more of the pain to bear.
  • We assume most countries stay at 10%. The impact of others rising to 20% may be smaller than the anti-avoidance hit, with the total now worth less than 0.4% to UK GDP.

European Tire Rubber Sector Faces Structural, Regulatory Headwinds

By Vinod Nedumudy

  • Plant closures signal Europe’s industrial competitiveness crisis  
  • Regulatory burdens over Europe’s retreading sector future  
  • Weak enforcement and oversight cloud UK ELT exports   

Korea: Short Selling Data Analysis: 3Q 2025

By Douglas Kim

  • We are introducing a new regular series called “Korea: Short Selling Data Analysis.” We will try to provide this insight on a quarterly basis.
  • Net short balance ratio for top 20 stocks in KOSPI averaged about 1.7% three months ago, much lower than current levels (3%).
  • The average short interest ratio of these top 20 stocks in KOSPI with the highest short balance ratio was 2.6x as of 10 July 2025. 

Asian Equities: Foreign Flows – Some Strength, Some Sustained Disappointments

By Manishi Raychaudhuri

  • Asian currencies bottomed out in early April. FII flows turned positive in May. Flows into Taiwan are recovering the fastest, followed by those into Korea. India’s recovery is relatively tepid. 
  • Flows into ASEAN remain negative – the lack of recovery, we think, is due to lack of macroeconomic catalysts, declining EPS estimates and trade related worries. We remain underweight ASEAN.
  • We are overweight Korea (recovering EPS, cheapest, flows accelerating). We like Taiwanese tech, key beneficiary of investors’ renewed AI enthusiasm. Overweight on India, despite its overvaluation, stems from bottom-up ideas.

Global FX: Keeping the bearish USD view

By At Any Rate

  • Discussion covers topics including dollar signals, $CNY fixes, tariffs, and observations on Swiss and sterling
  • Dollar remains bearish despite some systematic signals turning less bearish or even bullish
  • Client sentiment may be shifting tactically towards throwing in the towel on the bearish dollar trend due to technical patterns, but long-term view remains unchanged

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Global Commodities: 50% copper tariffs coming soon; now comes the copper hangover

By At Any Rate

  • Trump announced a 50% Section 232 base tariff on copper imports starting August 1st
  • The details of the tariff, including which products it applies to and any exemptions, remain unknown
  • The arbitrage between London LME prices and US Comex prices has widened following the tariff announcement, with implications for copper prices in both regions.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Don’t Get Fooled by Commodity Social Media Craziness

By The Commodity Report

  • While it may seem as a logical step to compare the current cash price with the forward futures contract, that’s unfortunately way too easy to justify such a statement.
  • In fact, it is even miss-information.
  • What makes more sense is to look at the input cost factors and the forecasts for these components that the USDA is providing. 

Bank of Japan on Hold

By Sharmila Whelan

  • In Japan, disastrous showing of the LDP party in the Tokyo local elections, was its political Kamikaze. The true test will come with this month’s Upper House elections. 
  • Voter frustration is mounting over the high cost of living. Real wages are contracting and retail sales volumes weakening.
  • The Bank of Japan has changed tack and Trading Post is following suit, now forecasting that the policy interest rate will stay on hold for the rest of 2025.

Asia base oils demand outlook: Week of 14 July

By Iain Pocock

  • Asia’s base oils demand shows signs of facing weaker-than-usual pressure from expected seasonal slowdown in consumption coming weeks.
  • Firmer prices for light grades relative to heavy grades, for Group I SN 500, and for prices in India point to ongoing pockets of buying interest even with seasonal slowdown in demand.
  • Prices for Group II heavy grades by contrast weaken vs light grades and vs Group I base oils.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Dian Swastatika Sentosa, SGX Rubber Future TSR20, Copper, Gold, Zhongjin Gold Corp A, Fugro NV, Norsk Hydro ASA, PetroTal, Plexus Holdings, Brenmiller Energy and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • LQ45 Index Rebalance Preview (Jul 2025): Identifying Potential Index Changes
  • European Tire Rubber Sector Faces Structural, Regulatory Headwinds
  • Global Commodities: 50% copper tariffs coming soon; now comes the copper hangover
  • Don’t Get Fooled by Commodity Social Media Craziness
  • Zhongjin Gold (SHA: 600489): Stable Growth, Strong Upside Potential
  • What’s News in Amsterdam – 14 July (Fugro | InPost | Triodos Bank | Corporate agenda)
  • Norsk Hydro ASA: Initiation of Coverage- Can Sustainability Investments Deliver Premium Profits in a Low-Carbon World?
  • PetroTal Corp (AIM: PTAL): 2Q25 Results in Line. Production Steady Despite Rig Delay.
  • Plexus Holdings plc – Hybridan Small Cap Feast: 07/07/2025
  • WTR Small-Cap Spotlight Recap (BNRG)


LQ45 Index Rebalance Preview (Jul 2025): Identifying Potential Index Changes

By Brian Freitas

  • The review period for the LQ45 Index July rebalance ended on 30 June. The changes should be announced later in two weeks, becoming effective after the close on 31 July.
  • We highlight 2 potential inclusions and 2 potential exclusions for the index at the rebalance, though there is a possibility that there are no constituent changes.
  • Both potential inclusions will have over 2x ADV to trade from passive trackers and the flow is significant for one stock.

European Tire Rubber Sector Faces Structural, Regulatory Headwinds

By Vinod Nedumudy

  • Plant closures signal Europe’s industrial competitiveness crisis  
  • Regulatory burdens over Europe’s retreading sector future  
  • Weak enforcement and oversight cloud UK ELT exports   

Global Commodities: 50% copper tariffs coming soon; now comes the copper hangover

By At Any Rate

  • Trump announced a 50% Section 232 base tariff on copper imports starting August 1st
  • The details of the tariff, including which products it applies to and any exemptions, remain unknown
  • The arbitrage between London LME prices and US Comex prices has widened following the tariff announcement, with implications for copper prices in both regions.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Don’t Get Fooled by Commodity Social Media Craziness

By The Commodity Report

  • While it may seem as a logical step to compare the current cash price with the forward futures contract, that’s unfortunately way too easy to justify such a statement.
  • In fact, it is even miss-information.
  • What makes more sense is to look at the input cost factors and the forecasts for these components that the USDA is providing. 

Zhongjin Gold (SHA: 600489): Stable Growth, Strong Upside Potential

By Rahul Jain

  • Consistent operating and financial performance over the past five years, supported by rising gold prices and disciplined cost control.
  • Recent H1 FY25 guidance signals over 50% profit growth, backed by expanding output, stable AISC, and targeted capex across key mines and refining assets.
  • Valuations remain undemanding at <10× FY27E P/E despite high earnings sensitivity to gold prices and improving margins, indicating re-rating potential.

What’s News in Amsterdam – 14 July (Fugro | InPost | Triodos Bank | Corporate agenda)

By The IDEA!

  • In this edition: • Fugro | awarded contracts for detailed site investigations at the Sørlige Nordsjø II • InPost | Growth Outside of Poland Pushed Into a Higher Gear • Triodos Bank | better than expected appetite for settlement offer • Corporate agenda | week 29 – 32

Norsk Hydro ASA: Initiation of Coverage- Can Sustainability Investments Deliver Premium Profits in a Low-Carbon World?

By Baptista Research

  • Norsk Hydro ASA, a leading global aluminum producer, recently presented its financial results for the first quarter of 2025.
  • The company’s performance reflects a mixture of operational achievements and challenges posed by fluctuating market dynamics and external pressures.
  • In terms of financial performance, Norsk Hydro reported an adjusted EBITDA of NOK 9.5 billion for the first quarter, supported by favorable conditions such as higher alumina and aluminum prices and advantageous currency movements.

PetroTal Corp (AIM: PTAL): 2Q25 Results in Line. Production Steady Despite Rig Delay.

By Auctus Advisors

  • 2Q25 production averaged 21,039 bbl/d, in line with expectations.
  • This includes 20,512 bbl/d from Bretana and 526 bbl/d from Los Angeles.
  • Output was affected by previously disclosed pump failures in four wells.

Plexus Holdings plc – Hybridan Small Cap Feast: 07/07/2025

By Hybridan

  • Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be delayed.
  • A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company’s Registration Document, requires additional time to enable finalisation ahead of the IPO.
  • The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. 

WTR Small-Cap Spotlight Recap (BNRG)

By Water Tower Research

  • The team at BNRG identified industrial heat early on as an often-overlooked segment in energy transition.
  • Industrial heat comprises about 25% of global energy use and emissions, while heat in general accounts for more than 50%.
  • BNRG’s innovative technology addresses a market need for a “heat battery” that stores heat generated from renewable electricity and delivers it on demand at a discount to the cost of natural gas, and with no emissions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Azoom, Qingdao Port International , Samsung C&T, MegaRobo Technologies, Shin Pro Maint, Inpost, Srg Takamiya, Sunmoon Food Company and more

By | Daily Briefs, Industrials

In today’s briefing:

  • TOPIX Inclusions: Who Is Ready (Jul 2025)
  • Quiddity Leaderboard CSI 300/​​500 Dec25: Some Changes to Expectations; Large Index Flows
  • Supreme Court’s Final Ruling on Samsung’s Lee Jae-Yong on 17 July: Impact on Samsung Group Companies
  • MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation
  • Shin Pro Maint (6086 JP): Q1 FY02/26 flash update
  • Research report: InPost | Growth Outside of Poland Pushed Into a Higher Gear
  • Research Alert: InPost | Growth Outside of Poland Pushed Into a Higher Gear
  • Takamiya (2445 JP) – Q4 Follow-Up
  • Industrials take sector lead in 2025 net institutional inflow


TOPIX Inclusions: Who Is Ready (Jul 2025)

By Janaghan Jeyakumar, CFA

  • Quiddity’s “Who is Ready” series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.
  • At the end of July 2025, GMO Financial Gate (4051 JP) and Azoom (3496 JP) will be included in the TOPIX Index.
  • Newly-Listed company Kitazato (368A JP) will also be included in the TOPIX index at the end of this month.

Quiddity Leaderboard CSI 300/​​500 Dec25: Some Changes to Expectations; Large Index Flows

By Janaghan Jeyakumar, CFA

  • CSI 300 represents the 300 largest stocks by market cap and liquidity from the Shanghai and Shenzhen Exchanges. CSI 500 is the next 500 names.
  • In this insight, we take a look at the potential ADDs and DELs leading the race for the semiannual index rebal event in December 2025.
  • Currently, we see 9 ADDs/DELs for the CSI 300 index and 45 ADDs/DELs for the CSI 500 index.

Supreme Court’s Final Ruling on Samsung’s Lee Jae-Yong on 17 July: Impact on Samsung Group Companies

By Douglas Kim

  • The Supreme Court of Korea plans to make a final ruling on Samsung’s Lee Jae-Yong on 17 July.
  • If the Supreme Court confirms this appellate court’s ruling, then Lee Jae-Yong would finally be cleared of all charges related to the Samsung C&T and Cheil Industries merger. 
  • The market is mostly expecting the confirmation of “not guilty” on all 19 charges on Lee Jae-Yong.

MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation

By Andrei Zakharov

  • MegaRobo Technologies, AI & robotics unicorn with focus on lab automation in life sciences and intelligent manufacturing, files to list IPO on Hong Kong Stock Exchange.
  • Founder led, AI native company was backed by Sinovation Ventures, Goldman Sachs, Asia Investment Capital, Robert Bosch Venture Capital, GGV Capital, and Joy Capital, among others.
  • The business is growing fast and increases the number of use cases across new verticals. However, negative free cash flows and operating losses are a headwind.

Shin Pro Maint (6086 JP): Q1 FY02/26 flash update

By Shared Research

  • Revenue increased 17.0% YoY to JPY6.7bn, driven by strong performance in Emergency and Preventive Maintenance Services.
  • Operating profit rose 30.6% YoY to JPY446mn, with an operating profit margin up 0.7pp YoY to 6.6%.
  • Shin Maint Holdings expanded market share by winning projects from competitors and forming a specialized air conditioning team.

Research report: InPost | Growth Outside of Poland Pushed Into a Higher Gear

By The IDEA!

  • Contents Summary and Conclusions Acquisition of Sending: a logical strategic move.
  • Sending: a bit more background Spanish e-commerce market: large and growing rapidly Market places dominating the landscape Spanish online shoppers still prefer home delivery High quality last mile delivery, yet can be inefficient Favourable environment for OOH and APMs in particular Sending deal is ticking all the boxes Now what does this deal mean financially?
  • Why is this so important?

Research Alert: InPost | Growth Outside of Poland Pushed Into a Higher Gear

By The IDEA!

  • Contents Summary and Conclusions Acquisition of Sending: a logical strategic move.
  • Sending: a bit more background Spanish e-commerce market: large and growing rapidly Market places dominating the landscape Spanish online shoppers still prefer home delivery High quality last mile delivery, yet can be inefficient Favourable environment for OOH and APMs in particular Sending deal is ticking all the boxes Now what does this deal mean financially?
  • Why is this so important?

Takamiya (2445 JP) – Q4 Follow-Up

By Sessa Investment Research

  • Takamiya (hereafter, the Company) reported its consolidated full-year earnings results for FY2025/3: net sales of JPY 43,827 mn (-0.7% YoY), operating profit of JPY 2,061 mn (-39.4% YoY), ordinary profit of JPY 1,856 mn (-48.1% YoY), and profit attributable to owners of parent (hereafter, net profit) of JPY 1,230 mn (-34.8% YoY).
  • Due to the postponement of the large-scale projects’ commencements, rental volumes fell short of initial expectations.
  • Additionally, due to delays in the delivery schedule of sales and OPE-MANE projects, the net sales saw only a slight increase.

Industrials take sector lead in 2025 net institutional inflow

By Geoff Howie

  • Institutions were net buyers of Singapore stocks, with a net inflow of S$94 million from Jul 4 to 10.
  • Industrials sector led 2025 net institutional inflows, booking S$629 million, surpassing telecommunications sector by Jul 10.
  • UOB led share buybacks with S$35.4 million, while Hongkong Land Holdings repurchased 946,000 shares at US$6.23 each.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Ascentage Pharma Group Corp, Anthem Biosciences, Unitedhealth Group, CSL Ltd, Astellas Pharma, Glenmark Pharmaceuticals, NanoViricides , Cybin and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Ascentage Pharma Top-Up Placement – Past Deals Didn’t Done Well, Stock up a Lot but Sector Is Strong
  • Anthem Biosciences IPO – Thoughts on Peer Comp and Valuation
  • Anthem BioSciences IPO Analysis ~ The Fastest-Growing Indian CRDMO
  • UnitedHealth Group’s Bold Healthcare Transformation—Is This The Future of Affordable Medicine?
  • Anthem Biosciences IPO: Despite 100% OFS, Worth Accumulating for Long-Term Compounding
  • Treasure Chest: CSL Not A One-Trick Pony
  • Astellas Pharma (4503 JP): Izervay on Strong Footing, Strategic Brands Key for Future
  • Glenmark’s R&D Leap: How a Large Biotech Liscensing Deal with AbbVie Could Change Its Fortune
  • NanoViricides Inc –
  • Cybin, Inc: Not All Psychedelic Treatments for Depression Are Created Equal


Ascentage Pharma Top-Up Placement – Past Deals Didn’t Done Well, Stock up a Lot but Sector Is Strong

By Sumeet Singh

  • Ascentage Pharma Group Corp (6855 HK) (AP) aims to raise around US$196m via  top-up placement.
  • The company has undertaken a number of deals in the past, with none of the deals having done well. Although stock momentum has been strong this year.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Anthem Biosciences IPO – Thoughts on Peer Comp and Valuation

By Akshat Shah

  • Anthem Biosciences (1234D IN) is looking to raise about US$397m in its India IPO.
  • Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
  • We have looked at the company’s past performance in our previous notes. In this note, we will talk about the peer comp and IPO valuations.

Anthem BioSciences IPO Analysis ~ The Fastest-Growing Indian CRDMO

By Sudarshan Bhandari

  • Anthem Biosciences (1234D IN) is launching a 3,395 crore IPO via a complete OFS, with a price band of INR 540–570 per share, open from July 14 to July 16.
  • Company is a fully integrated CRDMO with capabilities across drug discovery, development, and manufacturing for both small molecules and biologics, serving 550+ customers globally.
  • The company is undertaking a major capacity expansion, set to make its fermentation capacity over 6x larger than the second-largest Indian CRDMO player post-expansion.

UnitedHealth Group’s Bold Healthcare Transformation—Is This The Future of Affordable Medicine?

By Baptista Research

  • UnitedHealth Group’s first quarter 2025 results reveal a number of positive developments alongside several challenges that have led to a downward revision of the company’s adjusted earnings per share outlook.
  • The company now expects an adjusted earnings per share range of $26 to $26.50, down from previous estimates, partly attributed to higher-than-expected care activity within its Medicare Advantage business and changes in member profiles impacting revenue at Optum Health.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Anthem Biosciences IPO: Despite 100% OFS, Worth Accumulating for Long-Term Compounding

By Sreemant Dudhoria,CFA

  • Strong Revenue Momentum and Profitability:Anthem Biosciences (1234D IN) achieved INR 18.4bn in revenue in FY25, growing 25% CAGR over FY20–FY25,with industry-leading EBITDA margins of 36.8% and PAT margin of 23.4%
  • Unique Dual Capability in Biologics and Small Molecules:Among the few Indian CRDMOs with end-to-end capabilities across both small and large molecules, and technology-driven portfolio including ADCs, RNAi, peptides, and oligonucleotides
  • Peer-Leading Returns and Robust Pipeline: Anthem boasts the highest ROCE (26.9%) among Indian peers, with significant IP-backed revenue streams and global molecule commercialization. It is a BUY for long term.

Treasure Chest: CSL Not A One-Trick Pony

By FNArena

  • FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.
  • Today’s idea is on CSL

Astellas Pharma (4503 JP): Izervay on Strong Footing, Strategic Brands Key for Future

By Tina Banerjee

  • Astellas Pharma (4503 JP) announced that in Q1FY26 the sales of their drug Izervay (avacincaptad pegol intravitreal solution) in the U.S. market will be ¥15.9B (~$110M, up 25% YoY).
  • Strategic brands (Padcev, Izervay, Veozah, Vyloy, and Xospata) revenue expanded to ¥336B (+¥176B or +110% YoY) in FY25, representing 18% of the total revenue.
  • Astellas agreement with Evopoint Biosciences for a novel investigational clinical-stage antibody-drug conjugate (ADC) targeting CLDN18.2, will help expand its pipeline and augurs well given its expertise in similar therapies (Vyloy).

Glenmark’s R&D Leap: How a Large Biotech Liscensing Deal with AbbVie Could Change Its Fortune

By Sudarshan Bhandari

  • Glenmark Pharmaceuticals (GNP IN) signed the world’s fourth-largest biotech licensing deal by upfront value, receiving $700 million from AbbVie for its cancer drug ISB 2001. 
  • The agreement grants AbbVie global rights for key markets while Glenmark retains Emerging Market access, unlocking $1.9 billion in total potential proceeds. 
  • This transforms Glenmark into a net-cash company, funds IGI’s R&D pipeline, delays IPO needs, and positions India as a serious biotech innovation hub.

NanoViricides Inc –

By Zacks Small Cap Research

  • Zacks Small-Cap Research Note for NanoViricides, Inc. (NNVC)

Cybin, Inc: Not All Psychedelic Treatments for Depression Are Created Equal

By Water Tower Research

  • Compass Pathways’ Phase 3 COMP360 study readout lays down its first marker.
  • Compass Pathways’ (NASDAQ:CMPS) much anticipated top-line Part A readout of its COMP005 pivotal two-arm trial for its lead psilocybin-based monotherapy candidate for treatment-resistant depression (TRD), COMP360, has produced a statistically significant (p-value of <0.001) and clinically meaningful -3.6 mean difference in the MADRS scale comparing a one-time administered 25mg dose of COMP360 with placebo at six weeks in a 258-participant study.
  • Based on a statement from the independent Data and Safety Monitoring Board (DSMB), the Part A study resulted in no new or unexpected safety findings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars